Efficacy of iodine-123-15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid single photon emission computed tomography imaging in detecting myocardial ischemia in children with Kawasaki disease

Circulation Journal

Volumn 67, Issue 8, 2003, Pages 663-666

  Hoshina, Masaru ^a   Shiraishi, Hirohiko ^a   Igarashi, Hiroshi ^a   Kikuchi, Yutaka ^a   Ichihashi, Kou ^a   Momoi, Mariko Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

BMIPP; Coronary artery stenosis; Kawasaki disease; Myocardial ischemia; SPECT imaging

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ADOLESCENT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECANALIZATION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; THORAX PAIN;

EID: 0043095350     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.663     Document Type: Article

References (25)

1. Newburger JW. Treatment of Kawasaki disease. Lancet 1996; 347: 1128-1129.
2. Suzuki A, Kamiya T, Ono Y, Kinoshita Y, Kawamura S, Kimura K. Clinical significance of morphologic classification of coronary anerial segmental stenosis due to Kawasaki disease. Am J Cardiol 1993; 71: 1169-1173.
3. Matsunari I, Saga T, Taki J, Akashi Y, Hirai J, Wakasugi T, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: Assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285.
4. Tamaki N, Tadamura E, Kawamoto M, Magata Y, Yonekura Y, Fujibayashi Y, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995; 36: 1974-1980.
5. Knapp F Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: Current status and future perspectives. Eur J Nucl Med 1995; 22: 361-381.
6. Suzuki A, Takada Y, Nagasaka M, Kato R, Watanabe T, Shimokata K, et al. Comparison of resting beta-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Jpn Circ J 1997; 61: 133-138.
7. Nakata T, Hashimoto A, Eguchi M. Cardiac BMIPP imaging in acute myocardial infarction. Int J Card Imaging 1999; 15: 21-26.
8. Katsunuma E, Kurokawa S, Takahashi M, Fukuda N, Kurosawa T, Izumi T. Usefulness of BMIPP SPECT to evaluate myocardial viability, contractile reserve and coronary stenotic progression after reperfusion in acute myocardial infarction. Jpn Heart J 2001; 42: 435-449.
9. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5-40.
10. Iino T, Toyosaki N, Katsuki T, Noda T, Natsume T, Yaginuma T, et al. Evaluation of diseased coronary arterial branches by polar representations of thallium-201 rotational myocardial imaging. Clin Nucl Med 1987; 12: 688-693.
11. 123I-BMIPP myocardial imaging in two cases of ischemic heart disease. Kaku Igaku 1995; 32: 1117-1123.
12. Kondo C, Nakanishi T, Sonobe T, Tatara K, Momma K, Kusakabe K. Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease. Am J Cardiol 1993; 71: 681-685.
13. 201TI SPECT and treadmill exercise testing in patients with Kawasaki disease. Nucl Med Commun 2000; 21: 431-435.
14. Karasawa K, Ayusawa M, Noto N, Sumitomo N, Okada T, Harada K. Optimum protocol of technetium-99m tetrofosmin myocardial perfusion imaging for the detection of coronary stenosis lesions in Kawasaki disease. J Cardiol 1997; 30: 331-339.
15. Hamamichi Y, Ichida F, Tsubata S, Hirono K, Watanabe S, Rui C, et al. Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease. Circ J 2002; 66:63-69.
16. Fukuda T, Akagi T, Ishibashi M, Inoue O, Sugimura T, Kato H, Noninvasive evaluation of myocardial ischemia in Kawasaki disease: Comparison between dipyridamole stress thallium imaging and exercise stress testing. Am Heart J 1998; 135: 482-487.
17. Miyagawa M, Mochizuki T, Murase K, Tanada S, Ikezoe J, Sekiya M, et al. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. Circulation 1998; 98: 990-996.
18. Loevinger R, Berman M. MIRD Pamphlet 1: A schema for absorbed dose calculation for biologically distributed radionuclides. J Nucl Med 1968; 1: 9-14.
19. Ambrose KR, Owen BA, Goodman MM, Knapp FF Jr. Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987; 12: 486-491.
20. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
21. Nohara R, Okuda K, Ogino M, Hosokawa R, Tamaki N, Konishi J, et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37:1403-1407.
22. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
23. Matsunari I, Saga T, Taki J, Akashi Y, Hirai J, Wakasugi T, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: Assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285.
24. Knapp F Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022-1030.
25. Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: Comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54.